Explore more publications!
Niue Health Report
Got News to Share?

Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 11, 2025

Parsley Health Launches BYO Labs Review: The First Clinician-Led Service Turning Outside Lab Data Into Personalized Health Plans
December 11, 2025

Parsley Health Launches BYO Labs Review: The First Clinician-Led Service Turning Outside Lab Data Into Personalized Health Plans

Indeterminate GlobeNewswire
Graham and Courtney Rahal Foundation Donates $225,000 to SoldierStrong Through Vino for Vets Event
December 11, 2025

Graham and Courtney Rahal Foundation Donates $225,000 to SoldierStrong Through Vino for Vets Event

Indeterminate GlobeNewswire
Eclipse Energy Announces Collaborative Partnership with Weatherford Accelerating Commercialization of Subsurface Clean Energy Technologies
December 11, 2025

Eclipse Energy Announces Collaborative Partnership with Weatherford Accelerating Commercialization of Subsurface Clean Energy Technologies

Indeterminate GlobeNewswire
Approval of Roche/Genentech’s Gazyvaro Set to Reshape the EU5 Lupus Nephritis Treatment Landscape, According to Spherix Global Insights
December 11, 2025

Approval of Roche/Genentech’s Gazyvaro Set to Reshape the EU5 Lupus Nephritis Treatment Landscape, According to Spherix Global Insights

Indeterminate GlobeNewswire
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
December 11, 2025

PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited

Indeterminate GlobeNewswire
Acentra Health Names Patty Obermaier as Chief Growth Officer
December 11, 2025

Acentra Health Names Patty Obermaier as Chief Growth Officer

Indeterminate GlobeNewswire
NeXtGen™ Biologics Secures Favorable Outcome in Inter-Partes Patent Review
December 11, 2025

NeXtGen™ Biologics Secures Favorable Outcome in Inter-Partes Patent Review

Indeterminate GlobeNewswire
GRI Bio Announces Pricing of $8,000,000 Million Public Offering
December 11, 2025

GRI Bio Announces Pricing of $8,000,000 Million Public Offering

Indeterminate GlobeNewswire
Williamsburg Therapy Group Joins the Lumina Therapy Alliance, Strengthening the Nation’s Premier Network of High-End In-Person Mental Health Practices
December 11, 2025

Williamsburg Therapy Group Joins the Lumina Therapy Alliance, Strengthening the Nation’s Premier Network of High-End In-Person Mental Health Practices

Indeterminate GlobeNewswire
Nephros Launches the Nephros Water Institute to Lead National Water Safety Education
December 11, 2025

Nephros Launches the Nephros Water Institute to Lead National Water Safety Education

Indeterminate GlobeNewswire
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
December 11, 2025

MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire
Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities
December 11, 2025

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Indeterminate GlobeNewswire
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies
December 11, 2025

ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies

Indeterminate GlobeNewswire
2025 Holiday Gift Guide: Bob and Brad Announce Up to 42% Off Best-Selling Wellness Devices
December 11, 2025

2025 Holiday Gift Guide: Bob and Brad Announce Up to 42% Off Best-Selling Wellness Devices

Indeterminate GlobeNewswire
RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026
December 11, 2025

RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026

Indeterminate GlobeNewswire
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
December 11, 2025

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

Indeterminate GlobeNewswire
Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026
December 11, 2025

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Indeterminate GlobeNewswire
NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company
December 11, 2025

NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company

Indeterminate GlobeNewswire
OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain
December 11, 2025

OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain

Indeterminate GlobeNewswire
Surgery Partners, Inc. Announces Add-On Senior Notes Offering
December 11, 2025

Surgery Partners, Inc. Announces Add-On Senior Notes Offering

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions